Loading company…
Neotropix is a Malvern, US biotechnology company developing systemically deliverable oncolytic viruses for neuroendocrine cancers.
Founded in 2003 and based in Malvern, US, Neotropix develops and commercializes systemically deliverable oncolytic viruses for the treatment of neuroendocrine cancers. The company is at the Series B stage.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in